Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 00:00 | 01 Feb | 20.00 |
-0.30 (-1.48%) |
OPEN
20.45 |
HIGH
20.90 |
LOW
19.75 |
NSE 00:00 | 01 Feb | 19.95 |
-0.30 (-1.48%) |
OPEN
20.40 |
HIGH
20.90 |
LOW
19.70 |
OPEN | 20.45 |
PREVIOUS CLOSE | 20.30 |
VOLUME | 43807 |
52-Week high | 35.95 |
52-Week low | 19.50 |
P/E | 153.85 |
Mkt Cap.(Rs cr) | 449 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Financial Overview
Particulars (![]() |
2022 | 2021 | 2020 |
Net Sales | 1668.23 | 1541.82 | 2362.80 |
Operating Profit | 170.13 | 87.63 | 222.33 |
Other Income | 11.32 | 3.79 | 4.32 |
Interest | 78.81 | 112.03 | 125.82 |
Depreciation | 56.97 | 60.25 | 60.77 |
Profit Before Tax | 34.35 | -84.65 | 35.74 |
Tax | 9.03 | -11.50 | 5.68 |
Profit After Tax | 25.32 | -73.15 | 30.06 |
Share Capital | 22.43 | 22.43 | 22.43 |
Reserves | 1064.44 | 1038.31 | 1112.18 |
Net Worth | 1086.87 | 1060.74 | 1134.61 |
Loans | 867.95 | 913.87 | 790.09 |
Gross Block | 1562.95 | 1555.70 | 1508.81 |
Investments | 1.03 | 1.03 | 0.74 |
Cash | 17.74 | 25.43 | 21.23 |
Debtors | 446.98 | 374.59 | 396.87 |
Net Working Capital | 1145.58 | 1103.05 | 1024.11 |
Operating Profit Margin (%) | 10.20 | 5.68 | 9.41 |
Net Profit Margin (%) | 1.52 | -4.74 | 1.27 |
Earning Per Share (Rs) | 1.13 | -3.26 | 1.34 |
Dividend (%) | 0.00 | 0.00 | 5.00 |
Dividend Payout | 0.00 | 1.12 | 1.35 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices